Literature DB >> 33847920

Urinary Growth Differentiation Factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease.

Maria Dolores Sanchez-Niño1,2, Alberto Ortiz3,4, Maria Vanessa Perez-Gomez1,2, Soledad Pizarro-Sanchez1,2, Carolina Gracia-Iguacel1,2, Santiago Cano5, Pablo Cannata-Ortiz2,6, Jinny Sanchez-Rodriguez1,2, Ana Belen Sanz1,2.   

Abstract

BACKGROUND: Growth Differentiation Factor-15 (GDF15) is a member of the TGF-β superfamily. Increased serum GDF15 has been associated with increased risk of chronic kidney disease (CKD) progression. However, no prior studies have addressed the significance of urinary GDF15 in adult CKD.
METHODS: We measured serum and urinary GDF15 in a prospective cohort of 84 patients who underwent kidney biopsy and assessed their association with outcomes (survival, kidney replacement therapy) during a follow-up of 29 ± 17 months.
RESULTS: There was a statistically significant correlation between serum and urine GDF15 values. However, while serum GDF15 values increased with decreasing glomerular filtration rate, urinary GDF15 did not. Immunohistochemistry located kidney GDF15 expression mainly in tubular cells, and kidney GDF15 staining correlated with urinary GDF15 values. Urine GDF15 was significantly higher in patients with a histologic diagnosis of diabetic nephropathy than in diabetic patients without diabetic nephropathy. This was not the case for serum GDF15. Both serum and urine GDF15 were negatively associated with patient survival in multivariate models. However, when both urine and serum GDF15 were present in the model, lower urine GDF15 predicted patient survival [B coefficient (SEM) - 0.395 (0.182) p 0.03], and higher urine GDF15 predicted a composite of mortality or kidney replacement therapy [0.191 (0.06) p 0.002], while serum GDF15 was not predictive. Decision tree analysis yielded similar results. The area under the curve (AUC) of the receiver operating curve (ROC) for urine GDF15 as a predictor of mortality was 0.95 (95% CI 0.89-1.00, p < 0.001).
CONCLUSIONS: In conclusion, urinary GDF15 is associated with kidney histology patterns, mortality and the need for renal replacement therapy (RRT) in CKD patients who underwent a kidney biopsy.
© 2021. Italian Society of Nephrology.

Entities:  

Keywords:  Biomarker; Chronic kidney disease; Diabetic nephropathy; GDF15; Kidney biopsy

Mesh:

Substances:

Year:  2021        PMID: 33847920     DOI: 10.1007/s40620-021-01020-2

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  37 in total

1.  Growth Differentiation Factor-15 and Risk of CKD Progression.

Authors:  Viji Nair; Cassianne Robinson-Cohen; Michelle R Smith; Keith A Bellovich; Zeenat Yousuf Bhat; Maria Bobadilla; Frank Brosius; Ian H de Boer; Laurent Essioux; Ivan Formentini; Crystal A Gadegbeku; Debbie Gipson; Jennifer Hawkins; Jonathan Himmelfarb; Bryan Kestenbaum; Matthias Kretzler; Maria Chiara Magnone; Kalyani Perumal; Susan Steigerwalt; Wenjun Ju; Nisha Bansal
Journal:  J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 10.121

2.  CST3 and GDF15 ameliorate renal fibrosis by inhibiting fibroblast growth and activation.

Authors:  Young-Im Kim; Hyun-Woo Shin; Yang-Sook Chun; Jong-Wan Park
Journal:  Biochem Biophys Res Commun       Date:  2018-04-13       Impact factor: 3.575

Review 3.  Immunoregulation by members of the TGFβ superfamily.

Authors:  WanJun Chen; Peter Ten Dijke
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

4.  Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery.

Authors:  Charles Guenancia; Abdelkader Kahli; Gabriel Laurent; Olivier Hachet; Ghislain Malapert; Sandrine Grosjean; Claude Girard; Catherine Vergely; Olivier Bouchot
Journal:  Int J Cardiol       Date:  2015-06-17       Impact factor: 4.164

5.  Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury.

Authors:  Teresa A Zimmers; Xiaoling Jin; Edward C Hsiao; Sharon A McGrath; Aurora F Esquela; Leonidas G Koniaris
Journal:  Shock       Date:  2005-06       Impact factor: 3.454

6.  Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes.

Authors:  Magdalena Mazagova; Hendrik Buikema; Azuwerus van Buiten; Marry Duin; Maaike Goris; Maria Sandovici; Robert H Henning; Leo E Deelman
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-28

Review 7.  The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1.

Authors:  Klaus Unsicker; Björn Spittau; Kerstin Krieglstein
Journal:  Cytokine Growth Factor Rev       Date:  2013-06-18       Impact factor: 7.638

8.  Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.

Authors:  Ling Sun; Xuejun Zhou; Jianguang Jiang; Xuan Zang; Xin Chen; Haiyan Li; Haitao Cao; Qingjie Wang
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

9.  Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.

Authors:  Ling Sun; Xuejun Zhou; Jianguang Jiang; Xuan Zang; Xin Chen; Haiyan Li; Haitao Cao; Qingjie Wang
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

10.  Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.

Authors:  Abdelkader Kahli; Charles Guenancia; Marianne Zeller; Sandrine Grosjean; Karim Stamboul; Luc Rochette; Claude Girard; Catherine Vergely
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

View more
  4 in total

1.  Circulating Growth Differentiation Factor 15 Is Associated with Diabetic Neuropathy.

Authors:  Shao-Wen Weng; Wen-Chieh Chen; Feng-Chih Shen; Pei-Wen Wang; Jung-Fu Chen; Chia-Wei Liou
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

Review 2.  Aptamers Targeting Cardiac Biomarkers as an Analytical Tool for the Diagnostics of Cardiovascular Diseases: A Review.

Authors:  Natalia Komarova; Olga Panova; Alexey Titov; Alexander Kuznetsov
Journal:  Biomedicines       Date:  2022-05-06

3.  Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy.

Authors:  Lilia Abbad; Niki Prakoura; Arthur Michon; Rym Chalghoumi; Simone Reichelt-Wurm; Miriam C Banas; Christos Chatziantoniou
Journal:  Cells       Date:  2022-07-15       Impact factor: 7.666

4.  Does the Urinary Proteome Reflect ccRCC Stage and Grade Progression?

Authors:  Lucia Santorelli; Martina Stella; Clizia Chinello; Giulia Capitoli; Isabella Piga; Andrew Smith; Angelica Grasso; Marco Grasso; Giorgio Bovo; Fulvio Magni
Journal:  Diagnostics (Basel)       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.